Commercializing synthetic biology: Socio-ethical concerns and challenges under intellectual property regime

Journal of Commercial Biotechnology

Volumn 16, Issue 2, 2010, Pages 135-158

  Saukshmya, Trichi ^b   Chugh, Archana ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

^b NONE

Author keywords

Artifi cial life; Bioengineering; Biosafety; Genetic circuitry; Morality; Patents

Indexed keywords

BIO-ENERGY; BIODRUGS; BIOLOGICAL SCIENCE; COLLABORATIVE PROJECTS; DIVERSE APPLICATIONS; ETHICAL CONCERNS; ETHICAL IMPLICATIONS; HUMAN LIVES; METABOLIC PATHWAYS; NATURAL BIOLOGICAL SYSTEM; REVOLUTIONARY TECHNOLOGY; SYNTHETIC BIOLOGY;

BIOLOGICAL SYSTEMS; METALS; PATENTS AND INVENTIONS;

INVESTMENTS;

BIOCHEMISTRY; BIOENERGY; BIOENGINEERING; BIOLOGICAL WARFARE; BIOMEDICINE; BIOSAFETY; BIOTECHNOLOGY; COMMERCIAL PHENOMENA; CYTOLOGY; DRUG MARKETING; DRUG RESEARCH; FINANCIAL MANAGEMENT; GENETIC ENGINEERING; HIGH THROUGHPUT SCREENING; INFORMATION TECHNOLOGY; LAW; MEDICAL ETHICS; MOLECULAR BIOLOGY; MOLECULAR MODEL; MORALITY; PATENT; REVIEW; SOCIOECONOMICS; SOCIOLOGY; STANDARDIZATION;

EID: 77950539144     PISSN: 14628732     EISSN: 1478565X     Source Type: Journal    
DOI: 10.1057/jcb.2009.28     Document Type: Review

References (59)

1. Stemmer , W. P. , Crameri , A. , Ha , K. D. , Brennan , T. M. and Heyneker , H. L. ( 1995 ) Single-step assembly of a gene and entire plasmid from large numbers of oliogodeoxy-ribonucleotides. Gene 164 : 49-53.
2. Billings , L. and Endy , D. ( 2008 ) Seed's tear-outable tool for living in the 21st century. Department of Biological Engineering, Massachusetts Institute of Technology, http://openwetware.org/images/7/73/ 16cribsheet.pdf , accessed 31 December 2008.
3. Hobom , B. ( 1980 ) Gene surgery: On the threshold of synthetic biology. Medizinische Klinik 75 : 834-841.
4. Balmer , A. and Martin , P. ( 2008 ) Synthetic biology - social and ethical challenges, review for Bioscience for Society .Strategy (BSS) and panel of the Biotechnology and Biological Sciences Research Council (BBSRC) , http://www.bbsrc.ac .uk/organisation/policies/reviews/scientifi careas/ 0806syntheticbiology.pdf , May 2008, accessed on 10 January 2009.
5. Sismour , A. M. and Benner , S. A. ( 2005 ) Synthetic biology. Expert Opinion on Biological Therapy 5 (11) : 1409-1414. (Pubitemid 41579425)
6. Benner , S. A. and Sismour , M. A. ( 2005 ) Synthetic biology. Nature Reviews Genetics 6 : 533-543. (Pubitemid 40910430)
7. European Commission. ( 2005 ) Synthetic Biology - Applying Engineering to Biology. Report of a NEST High-Level Expert Group, EUR 21796.
8. Benner , S. A. (ed.) ( 1988 ) Redesigning the Molecules of Life. Heidelberg, Germany: Springer , pp. 115 - 175.
9. Bruggeman , F. J. and Westerhoff , H. V. ( 2002 ) The nature of systems biology. Trends in Microbiology 15 (1) : 45-50.
10. Bhutkar , A. ( 2005 ) Synthetic biology: Navigating the challenges ahead. Journal of Biolaw and Business 8 : 19-29. (Pubitemid 350042549)
11. A host cell that has reduced and reoriented metabolic needs can generate biological energy applicable to a broad range of industrial fi elds including energy industrial organic compounds pharmaceuticals CO 2 sequestration, fi ne chemicals, and environmental remediation, http://www .syntheticgenomics.com/ press/2005-06-29.htm , accessed on 2 January 2008.
12. Patrinos , A. ( 2008 ) Renewing America's future: Energy visions of tomorrow, today. Select Committee on Energy Independence and Global Warming, 31 July 2008.
13. European Commission. ( 2007 ) Synthetic Biology - A NEST Pathfi nder Initiative, EUR 22426.
14. The COBIOS consortium will utilize methods from system dynamics and control theory to develop and implement modular control networks.
15. Obama Administration announces billions in lending authority for renewable energy projects and to modernize the grid, Department of Energy, Press Release, 29 July 2009.
16. The Bill and Melinda Gates Foundation donated $ 42.6 million over fi ve years (beginning) to a collaboration between the Institute for OneWorld Health, UC Berkeley and Amyris Biotechnologies to develop a synthetic form of artemisinin, an antimalarial drug.
17. EraGen Biosciences closes on $ 12 million in series A fi nancing. ( 2006 ) http://eragen.senscia.com/ UploadedImg/Press%20Releases/PR0601EraGen .pdf , accessed on 31 December 2008.
18. European Commission. ( 2007 ) Synthetic Biology , A NEST Pathfi nder Initiative, Directorate-General for Research.
19. Balmer , A. and Martin , P. ( 2008 ) Synthetic Biology - Social and Ethical Challenges. Biotechnology and Biological Sciences Research Council (BBSRC) , http://www.bbsrc.ac.uk/organisation/policies/ reviews/scientifi careas/0806syntheticbiology.pdf , May 2008, accessed on 10 January 2009.
20. ETC Group. ( 2007 ) Extreme Genetic Engineering: An Introduction to Synthetic Biology. Canada.
21. Garfi nkel , M. S. , Endy , D. , Epstien , G. L. and Friedman , R. M. ( 2007 ) Synthetic genomics: Options for governance. Industrial Biotechnology 3 (4) : 333-365.
22. Tucker , J. B. and Zilinskas , R. A. ( 2006 ) The promise and perils of synthetic biology , The New Atlantis , 1 - 12 : 25-45.
23. Chopra , P. and Kamma , A. ( 2006 ) Engineering life through synthetic biology. In Silico Biology 6 : 401-410. (Pubitemid 44857637)
24. Connor , T. ( 2007 ) Genetically modifi torts: Enlisting the tort system to regulate agricultural contamination by biotech crops. University of Cincinnati Law Review 75 : 1187-1215.
25. Cullet , P. ( 2006 ) Liability and redress for modern biotechnology. Yearbook of International Environmental Law 15 : 165-195.
26. Nordlee , J. A. , Taylor , S. L. , Townsend , J. A. , Thomas , L. A. and Bush , R. K. ( 1996 ) Identifi cation of a Brazil-nut allergen in transgenic soybeans. New England Journal of Medicine 334 : 688-692. (Pubitemid 26079802)
27. Breithaupt , H. ( 2006 ) The engineer's approach to biology. EMBO Reports 7 (1) : 21-23.
28. Cho , M. K. , Magnus , D. , Caplan , A. L. and McGee , D. ( 1999 ) Policy forum: Genetics. Ethical considerations in synthesizing a minimal genome. Science 286 (5447) : 2087 , 2089-2090
29. Editorial. ( 2004 ) Futures of artifi cial life. Nature 431 (7009) : 613.
30. Thomas , J. ( 2007 ) ' Patenting Pandora's Bug '. ETC Group, Canada.
31. Cello , J. , Paul , A. V. and Wimmer , E. ( 2002 ) Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science 297 : 1016-1018. (Pubitemid 34856035)
32. Dewannieux , M. et al ( 2006 ) Identifi cation of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Research 16 : 1548-1556. (Pubitemid 44878493)
33. Garfi nkel , M. S. , Endy , D. , Epstein , G. L. and Friedman , R. M. ( 2007 ) Synthetics genomes: Options for governance. Biosecurity and Bioterrorism 5 (4) : 359-362.
34. The Darker Bioweapons Future, CIA - Directorate of Intelligence, 3 November 2003.
35. Postnote, Synthetic biology, January 2008, Number 298, http://www.parliament.uk/documents/ upload/postpn298.pdf , accessed 15 January 2009.
36. Article I, Signed at London, Moscow and Washington on 10 April 1972. Entered into force on 26 March 1975.
37. Jefferson , T. ( 2009 ) Isaac McPherson Monticello, 13 August 1813, http://www.temple.edu/ lawschool/dpost/mcphersonletter.html , accessed 2 January 2009.
38. Kewanee Oil Co. v. Bicron Corp., 416 US 470 (1974).
39. Rai , A. and Boyle , J. ( 2007 ) Synthetic biology: Caught between property rights, the public domain, and the commons. PLoS Biology 5 (3) : 389-393. (Pubitemid 46422962)
40. Singsangob , A. ( 2009 ) A validity of Shrinkwrap and Clickwrap license agreements in the USA: Should we follow UCITA? , http://legalaid.bu.ac.th/fi les/ articles/A-VALID-OF-SWL.pdf , accessed 25 January 2009.
41. Scott , M. D. ( 1998 ) Electronic contracting: The use of clickwrap licenses. L.W. Glass-Cle
42. Diamond v. Chakrabarty , 447 US 303 (1980).
43. United States Code Title 35 - Patents, Section 101 - Inventions patentable Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefore, subject to the conditions and requirements of this title.
44. American Fruit Growers v. Brogdex Co., 8 U.S.P.Q. March 1931).
45. American Fruit Growers v. Brogdex Co., 8 U.S.P.Q. 131 (3 March 1931).
46. Harvard College v. Canada (Commissioner of Patents), 2002 Carswell Nat 3434 (21 May 2002).
47. - Egea Biosciences, Method for synthesizing entire genes and networks of genes.
48. WO 06076679 A1, Codon Devices Inc., Compositions and methods for protein design.
49. Fleischmann , R. D. and Craig Venter , J. et al , US 2005/0131222 A1, Nucleotide sequence of the Haemophilus infl uenzae Rd genome, fragments thereof, and uses thereof.
50. Holt US 2007/0243617 A1, Modular Genomes for Synthetic Biology and Metabolic Engineering.
51. Matsuda et al , US 7,238,514 B2, Diterpene producing unicellular organism.
52. McAdams et al , US 5,914,891, A system and method for simulating the operation of biochemical networks includes a computer having a computer memory used to store a set of objects, each object representing a biochemical mechanism in the biochemical network to be simulated.
53. Goodbye, Dolly.Hello, Synthia!, J. Craig Venter Institute seeks monopoly patents on the world's fi rst-ever human-made life form, http://www .etcgroup.org/en/materials/publications.html? pub-id=631 , accessed 31 December 2008.
54. United States Code Title 35 - Patents, Section 112 - Specifi cation. The specifi cation shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention.
55. ' It is a bedrock principle of patent law that the claims of a patent defi ne the invention to which the patentee is entitled the right to exclude ' , Phillips v. AWH Corp. , 415 F.3d 1303 (Fed. Cir. 2005) (en banc), citing Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc. , 381 F.3d 1111 (Fed. Cir. 2004).
56. Innova/Pure Water, Inc. v. Safari Water Filtration Systems, Inc., 381 F.3d 1111Fed. Cir. 2004
57. Iwasaka , K. ( 2000 ) Chakrabarty to chimeras: The growing need for evolutionary biology in patent law. Yale Law Journal 109 (6) : 1505-1534.
58. Extreme Genetic Engineering, An Introduction to Synthetic Biology, ETC Group, January, 2007.
59. Animal Legal Defense Fund Donald J. Quigg, 932 F.2d 920 (1991).